Business Wire (Mon, 10:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
252 people get CSII articles and Market Currents by email alert.
Get email alerts on CSII »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 24, 2013)
-
Business Wire (Mar 20, 2013)
-
Business Wire (Mar 19, 2013)
-
Business Wire (Mar 15, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Mar 11, 2013)
-
Business Wire (Feb 25, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Jan 30, 2013)
-
Business Wire (Jan 25, 2013)
-
Business Wire (Jan 23, 2013)
-
Business Wire (Jan 16, 2013)
-
Business Wire (Nov 27, 2012)
-
Lee Ainslie's Maverick Capital Sells Cardiovascular Systems WarrantsMarket Folly • Fri, Dec 3, 2010
-
Maverick Issues Correction on Cardiovascular Systems HoldingMarket Folly • Fri, Apr 3, 2009
-
Maverick Capital Files 13G for Cardiovascular SystemsMarket Folly • Tue, Mar 17, 2009
-
Top Medtech Analyst Points To Post-Obamacare OpportunitiesLife Sciences Report • Thu, Sep 6, 2012
-
Spectranetics Still Searching For Traction In PeripheralStephen Simpson • Tue, Feb 21, 2012
-
PAD Awareness Month Brings Cardiovascular Companies to the ForefrontDouglas Cress • Thu, Sep 16, 2010
-
Big Lineup of Healthcare Stocks Crack the Russell 3000 IndexM. E. Garza • Wed, Jul 1, 2009
-
Business Wire (Mon, 10:00AM)
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 24, 2013)
-
Business Wire (Mar 20, 2013)
-
Business Wire (Mar 19, 2013)
-
Business Wire (Mar 15, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Mar 11, 2013)
-
Business Wire (Feb 25, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Jan 30, 2013)
-
Business Wire (Jan 25, 2013)
-
Business Wire (Jan 23, 2013)
-
Business Wire (Jan 16, 2013)
-
Business Wire (Nov 27, 2012)
-
Business Wire (Nov 6, 2012)
-
Business Wire (Oct 30, 2012)
-
Business Wire (Oct 23, 2012)
CSII vs. ETF Alternatives
Company Description
Currently, there's no company description for CSII.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, January 31, 4:09 PM Despite the marketshare gains Cardiovascular Systems (CSII) has made with its Diamondback and Stealth devices for treating narrowed or blocked arteries in the leg, the real value in the company may lie in its takeout potential, says Seeking Alpha contributor Stephen Simpson. CR Bard, Cook, BSX, JNJ, MDT and ABT all have sales forces in the peripheral treatment space, making them solid candidates for a possible buyout of CSII. Comment! [Healthcare, M&A]
LATEST REPLIES

